Editas Medicine Inc. (NASDAQ:EDIT) went down by -3.21% during the previous trading session, and it is maintaining the win ahead of Wednesday’s trading session. The share price of the Biotechnology giant went up by $29.89 to trade ended Wednesday trading at $30.88. This is down from the $30.88 price recorded on Tuesday’s trading session. Thanks to this latest performance, EDIT is closer to the higher price 52-week target of $55.00 and further from the lowest price target of $27.00. Its performance from the start of the year has also been positive, with EDIT up by 0.95% year-to-date.
Editas Medicine Inc. (EDIT) started the day trading at $30.84 and recorded an intraday high of $31.7299. It also recorded an intraday low of $29.63 during Wednesday’s trading session. Editas Medicine Inc. is a very active stock that recorded a trading volume that is more than 31.49% of the average daily trading volume on Wednesday. The stock’s trading volume on Wednesday was 1337270, which is more than 31.49 of the total average daily trading volume of 916.12K.
Editas Medicine Inc. (NASDAQ:EDIT) 2020 Performance Impressive
The increase in EDIT’s stock price on Wednesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of EDIT currently stands at $34.37, which is higher than the current trading price of the stock by 13.03%. However, EDIT’s current trading price is -113.35% lower than the 52-week low price of $14.01. In terms of trading volume, Editas Medicine Inc. currently experienced healthy participation during the last trading session. 1337270 shares of Editas Medicine Inc. were traded on the stock exchange on Wednesday, which is more than 31.49% of the 916.12K average trading volume of the stock.
The performance of the stock has been positive over the past year. EDIT’s performance over the past one year has seen it surge by 30.01%, while the stock has gone down by -3.98% in the last six months. The quarterly performance of EDIT currently stands at 63.42%, and it is up by 10.46% in the last month. The only positive figure was from the weekly performance, which currently reads 8.73%. At the time of writing EDIT’s report, the company has a total market cap of $1.52B, making it one of the largest publicly-traded companies in the world.Editas Medicine Inc. also has over 208 employees all over the world.
EDIT Insider Activities
For Editas Medicine Inc., insiders hold 75.10% of all company shares. The insider transactions over the past six months are up by 4.70%. During that period, insiders bought 65,195 shares in 4 transactions. In that same period, insiders sold 6,322 of their shares in 3 transactions. After these transactions, insiders at Editas Medicine Inc. now hold 1.31M shares, which is over 75.78% of the total company stocks. Institutional investors currently hold a large chunk of the EDIT shares, as they control 2.41% of the company’s total stock.
EDIT Fundamental Analysis
For Editas Medicine Inc., the stock’s diluted earnings per share (EPS) stands at -2.76. In the coming year, analysts expect the EPS to be -3.36. The stock’s EPS growth this year is -14.60%, -46.80% in the previous five years. In terms of revenue, Editas Medicine Inc.’s quarterly sales (YOY) is shrinking at -0.80, which is higher than the average annual revenue of -46.80% over the past half a decade.
The Return on Investment (ROI) on Editas Medicine Inc.’s stock currently stands at -53.70%.
EDIT Analysts Prediction
and Chardan Capital Markets reiterate their Buy position on the stock ($72.50 and $55).
Chardan Capital Markets and Chardan Capital Markets also believe that Editas Medicine Inc.’s stock is outperforming at the moment.
EDIT Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of EDIT currently stands at 7.77%, while the SMA50 is 17.11%. The biggest one is the SMA200, which is currently reading 19.28% ahead of Wednesday’s trading session. The Relative Strength Index of this stock is 58.99.